More articles from Cancer Biology and Signal Transduction

JAK1/STAT3 Activation through a Proinflammatory Cytokine Pathway Leads to Resistance to Molecularly Targeted Therapy in Non–Small Cell Lung Cancer
Kazuhiko Shien, Vassiliki A. Papadimitrakopoulou, Dennis Ruder, Carmen Behrens, Li Shen, Neda Kalhor, Juhee Song, J. Jack Lee, Jing Wang, Ximing Tang, Roy S. Herbst, Shinichi Toyooka, Luc Girard, John D. Minna, Jonathan M. Kurie, Ignacio I. Wistuba, Julie G. Izzo

Molecular Cancer Therapeutics Oct 2017, 16 (10) 2234-2245; DOI: 10.1158/1535-7163.MCT-17-0148
Decitabine Priming Enhances Mucin 1 Inhibition Mediated Disruption of Redox Homeostasis in Cutaneous T-Cell Lymphoma
Salvia Jain, Abigail Washington, Rebecca Karp Leaf, Parul Bhargava, Rachael A. Clark, Thomas S. Kupper, Dina Stroopinsky, Athalia Pyzer, Leandra Cole, Myrna Nahas, Arie Apel, Jacalyn Rosenblatt, Jon Arnason, Donald Kufe, David Avigan

Molecular Cancer Therapeutics Oct 2017, 16 (10) 2304-2314; DOI: 10.1158/1535-7163.MCT-17-0060
Bypassing Drug Resistance Mechanisms of Prostate Cancer with Small Molecules that Target Androgen Receptor–Chromatin Interactions
Kush Dalal, Meixia Che, Nanette S. Que, Aishwariya Sharma, Rendong Yang, Nada Lallous, Hendrik Borgmann, Deniz Ozistanbullu, Ronnie Tse, Fuqiang Ban, Huifang Li, Kevin J. Tam, Mani Roshan-Moniri, Eric LeBlanc, Martin E. Gleave, Daniel T. Gewirth, Scott M. Dehm, Artem Cherkasov, Paul S. Rennie

Molecular Cancer Therapeutics Oct 2017, 16 (10) 2281-2291; DOI: 10.1158/1535-7163.MCT-17-0259
Inactivation of the Kinase Domain of CDK10 Prevents Tumor Growth in a Preclinical Model of Colorectal Cancer, and Is Accompanied by Downregulation of Bcl-2
Louis-Bastien Weiswald, Mohammad R. Hasan, John C.T. Wong, Clarissa C. Pasiliao, Mahbuba Rahman, Jianhua Ren, Yaling Yin, Samuel Gusscott, Sophie Vacher, Andrew P. Weng, Hagen F. Kennecke, Ivan Bièche, David F. Schaeffer, Donald T. Yapp, Isabella T. Tai

Molecular Cancer Therapeutics Oct 2017, 16 (10) 2292-2303; DOI: 10.1158/1535-7163.MCT-16-0666
ABCB1 Mediates Cabazitaxel–Docetaxel Cross-Resistance in Advanced Prostate Cancer
Alan P. Lombard, Chengfei Liu, Cameron M. Armstrong, Vito Cucchiara, Xinwei Gu, Wei Lou, Christopher P. Evans, Allen C. Gao

Molecular Cancer Therapeutics Oct 2017, 16 (10) 2257-2266; DOI: 10.1158/1535-7163.MCT-17-0179
The IGF1R/INSR Inhibitor BI 885578 Selectively Inhibits Growth of IGF2-Overexpressing Colorectal Cancer Tumors and Potentiates the Efficacy of Anti-VEGF Therapy
Michael P. Sanderson, Marco H. Hofmann, Pilar Garin-Chesa, Norbert Schweifer, Andreas Wernitznig, Stefan Fischer, Astrid Jeschko, Reiner Meyer, Jürgen Moll, Thomas Pecina, Heribert Arnhof, Ulrike Weyer-Czernilofsky, Stephan K. Zahn, Günther R. Adolf, Norbert Kraut

Molecular Cancer Therapeutics Oct 2017, 16 (10) 2223-2233; DOI: 10.1158/1535-7163.MCT-17-0336
The Tumor-Suppressor Protein OPCML Potentiates Anti–EGFR- and Anti–HER2-Targeted Therapy in HER2-Positive Ovarian and Breast Cancer
Elisa Zanini, Louay S. Louis, Jane Antony, Evdoxia Karali, Imoh S. Okon, Arthur B. McKie, Sebastian Vaughan, Mona El-Bahrawy, Justin Stebbing, Chiara Recchi, Hani Gabra

Molecular Cancer Therapeutics Oct 2017, 16 (10) 2246-2256; DOI: 10.1158/1535-7163.MCT-17-0081
Ormeloxifene Suppresses Prostate Tumor Growth and Metastatic Phenotypes via Inhibition of Oncogenic β-catenin Signaling and EMT Progression
Bilal Bin Hafeez, Aditya Ganju, Mohammed Sikander, Vivek K. Kashyap, Zubair Bin Hafeez, Neeraj Chauhan, Shabnam Malik, Andrew E. Massey, Manish K. Tripathi, Fathi T. Halaweish, Nadeem Zafar, Man M. Singh, Murali M. Yallapu, Subhash C. Chauhan, Meena Jaggi

Molecular Cancer Therapeutics Oct 2017, 16 (10) 2267-2280; DOI: 10.1158/1535-7163.MCT-17-0157
mTORC1 Inhibition Induces Resistance to Methotrexate and 6-Mercaptopurine in Ph⁺ and Ph-like B-ALL
Thanh-Trang T. Vo, J. Scott Lee, Duc Nguyen, Brandon Lui, William Pandori, Andrew Khaw, Sharmila Mallya, Mengrou Lu, Markus Müschen, Marina Konopleva, David A. Fruman

Molecular Cancer Therapeutics Sep 2017, 16 (9) 1942-1953; DOI: 10.1158/1535-7163.MCT-17-0024
FBW7-Dependent Mcl-1 Degradation Mediates the Anticancer Effect of Hsp90 Inhibitors
Jingshan Tong, Shuai Tan, Zaneta Nikolovska-Coleska, Jian Yu, Fangdong Zou, Lin Zhang

Molecular Cancer Therapeutics Sep 2017, 16 (9) 1979-1988; DOI: 10.1158/1535-7163.MCT-17-0032

Main menu

User menu

Search

More articles from Cancer Biology and Signal Transduction

Pages

Articles

Info for

About MCT